UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934.

 

 

 

PROTECT PHARMACEUTICAL CORP

(Exact name of registrant as specified in its charter)

 

 

 

4876 Cecile Ave

Las Vegas NV 89115

(954) 292-0033

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, par value $0.005 per share

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)   [X]
Rule 12g-4(a)(2)   [X]
Rule 12h-3(b)(1)(i)   [X]
Rule 12h-3(b)(1)(ii)   [X]
Rule 15d-6   [  ]
Rule 15d-22(b)   [  ]

 

Approximate number of holders of record as of the certification or notice date: 103

 

 

Protect Pharmaceutical Corp.

   
Date: June 11, 2019 By: /s/ Una Taylor
  Name:  Una Taylor
  Title: President

 

 

 

 
 

Protect Pharmaceutical (PK) (USOTC:PRTT)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025 Plus de graphiques de la Bourse Protect Pharmaceutical (PK)
Protect Pharmaceutical (PK) (USOTC:PRTT)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025 Plus de graphiques de la Bourse Protect Pharmaceutical (PK)